Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 12, 2019 - Issue
Submit an article Journal homepage
150
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?

Camille Maadjhou Mba1 Department of Physiological Sciences/Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, CameroonCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6186-8944
ORCID Icon,
Wilfred Mbacham1 Department of Physiological Sciences/Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
,
Eugène Sobngwi2 Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon;3 National Obesity Center and Endocrine and Metabolic Diseases Unit, Yaoundé Central Hospital, Yaoundé, Cameroon
&
Jean Claude Mbanya2 Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon;3 National Obesity Center and Endocrine and Metabolic Diseases Unit, Yaoundé Central Hospital, Yaoundé, Cameroon
Pages 2791-2797 | Published online: 31 Dec 2019

References

  • Cho NH , Shaw JE , Karuranga S , et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract . 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023 29496507
  • Chehade JM , Gladysz M , Mooradian AD . Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs . 2013;73(4):327–339. doi:10.1007/s40265-013-0023-5 23479408
  • Klop B , Elte JWF , Castro Cabezas M . Dyslipidemia in obesity: mechanisms and potential targets. Nutrients . 2013;5(4):1218–1240. doi:10.3390/nu5041218 23584084
  • Jaiswal M , Schinske A , Pop-Busui R . Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab . 2014;28(3):325–338. doi:10.1016/j.beem.2013.12.001 24840262
  • Schulz R , Schlüter K-D , Laufs U . Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9). Basic Res Cardiol . 2015;110(2):4. doi:10.1007/s00395-015-0463-z 25600226
  • Ruscica M , Tokgözoğlu L , Corsini A , Sirtori CR . PCSK9 inhibition and inflammation: a narrative review. Atherosclerosis . 2019;288:146–155. doi:10.1016/j.atherosclerosis.2019.07.015 31404822
  • Momtazi-Borojeni AA , Sabouri-Rad S , Gotto AM , et al. PCSK9 and inflammation: a review of experimental and clinical evidence. Eur Heart J Cardiovasc Pharmacother . 2019;5(4):237–245. doi:10.1093/ehjcvp/pvz022 31236571
  • Lakoski SG , Lagace TA , Cohen JC , Horton JD , Hobbs HH . Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab . 2009;94(7):2537–2543. doi:10.1210/jc.2009-0141 19351729
  • Caselli C , Del Turco S , Ragusa R , et al. Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina. Cardiovasc Diabetol . 2019;18(1):144. doi:10.1186/s12933-019-0949-3 31672148
  • Miao J , Manthena PV , Haas ME , et al. The role of insulin in the regulation of PCSK9. Arterioscler Thromb Vasc Biol . 2015;35(7):1589–1596. doi:10.1161/ATVBAHA.115.305688 26023080
  • Dong B , Wu M , Li H , et al. Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J Lipid Res . 2010;51(6):1486–1495. doi:10.1194/jlr.M003566 20048381
  • Schmidt AF , Swerdlow DI , Holmes MV , et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol . 2017;5(2):97–105. doi:10.1016/S2213-8587(16)30396-5 27908689
  • Saavedra YGL , Dufour R , Davignon J , Baass A . PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Arterioscler Thromb Vasc Biol . 2014;34(12):2700–2705. doi:10.1161/ATVBAHA.114.304406 25278291
  • Brouwers MC , Troutt JS , Van Greevenbroek MM , et al. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: the CODAM study. Atherosclerosis . 2011;217(1):263–267.21497351
  • Whitley E , Ball J . Statistics review 4: sample size calculations. Crit Care London Engl . 2002;6(4):335–341. doi:10.1186/cc1521
  • Levenson AE , Shah AS , Khoury PR , et al. Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women. Pediatr Diabetes . 2017;4:2–8.
  • Yang S-H , Li S , Zhang Y , et al. Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes. Diabetes Metab Res Rev . 2016;32(2):193–199. doi:10.1002/dmrr.v32.2 26377225
  • Yadav NK , Thanpari C , Shrewastwa MK , Mittal RK . Comparison of lipid profile in type-2 obese diabetics and obese non-diabetic individuals. a hospital based study from Western Nepal. Kathmandu Univ Med J . 2012;10(39):44–47. doi:10.3126/kumj.v10i3.8017

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.